February 22, 2017 / 6:30 PM / 6 months ago

BRIEF-Penumbra reports results of the ASTER Trial

Feb 22 (Reuters) - Penumbra Inc:

* Independent study supports use of Penumbra aspiration as frontline thrombectomy therapy for acute ischemic stroke

* 85.4 percent of patients treated with Penumbra's aspiration system achieved primary endpoint of TICI 2b/3 at end of procedure

* 63% patients treated with aspiration system achieved secondary endpoint of TICI 2b/3 after frontline treatment versus 67.7% with stent retrievers Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below